Wang, Kai <br/><br/>
Celecoxib, a selective cyclooxygenase-2 inhibitor, decreases monocyte chemoattractant protein-1 expression and neointimal hyperplasia in the rabbit atherosclerotic balloon injury model.  [electronic resource] 

 -  Journal of cardiovascular pharmacology  Jan 2005 
 - 61-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0160-2446 
<br/><br/><label>Standard No.: </label>10.1097/00005344-200501000-00011  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angioplasty, Balloon<br/>Animals<br/>Arteriosclerosis--etiology<br/>Celecoxib<br/>Chemokine CCL2--antagonists & inhibitors<br/>Cyclooxygenase 1<br/>Cyclooxygenase 2<br/>Cyclooxygenase 2 Inhibitors<br/>Cyclooxygenase Inhibitors--pharmacokinetics<br/>Female<br/>Hyperplasia<br/>Iliac Artery--drug effects<br/>Male<br/>Matrix Metalloproteinase 2--biosynthesis<br/>Matrix Metalloproteinase 9--biosynthesis<br/>Matrix Metalloproteinase Inhibitors<br/>Prostaglandin-Endoperoxide Synthases--biosynthesis<br/>Pyrazoles--pharmacokinetics<br/>Rabbits<br/>Stents<br/>Sulfonamides--pharmacokinetics<br/>Tunica Intima--drug effects